(Q33500120)

English

Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.). (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

author name string

Thomas P

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Kleisbauer JP

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Robinet G

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Clavier J

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Poirier R

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Vernenegre A

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Bonnaud F

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Taytard A

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Paillotin D

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pommier De Santi P

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Barriere JR

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pignon T

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

71-81

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Chemotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical and clinical experience with cisplatin and carboplatin and simultaneous radiation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin as a potentiator of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged 'in-use' conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900047-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(97)00047-0

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

release_xp2lzx7pazhnlg4h7chgpxxwyu

1 reference

https://api.fatcat.wiki/v0/release/xp2lzx7pazhnlg4h7chgpxxwyu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33500120&oldid=1977227879"